Evaluation on Efficacy and Safety of Arsenic Trioxide Plus Transcatheter Arterial Chemoembolization Versus Transcatheter Arterial Chemoembolization alone for Unresectable Primary Liver Cancer

Currently, some clinical trials of arsenic trioxide (As203) plus transcatheter arterial chemoembolization (TACE) in the treatment of unresectable primary liver cancer (PLC) had been conducted, but the results were controversial. Therefore, we performed a meta-analysis on 14 clinical trials (1076 cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haitao, Zhou, Sijing, Shen, Ruifen, Luo, Shuimei, Li, Lina, Lin, Heng, Chen, Huijuan, Liao, Ziyuan, Lin, Wanzun, Xie, Xianhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747392/
https://www.ncbi.nlm.nih.gov/pubmed/29072394
http://dx.doi.org/10.22034/APJCP.2017.18.10.2695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747392/
https://www.ncbi.nlm.nih.gov/pubmed/29072394
http://dx.doi.org/10.22034/APJCP.2017.18.10.2695

Ejemplares similares